9 results about "Urinary Tract Diseases" patented technology

The present disclosure relates to flavor compositions and pet food products for preventing and / or treating chronic kidney disease (CKD) and / or urinary tract disease in an animal. In certain embodiments, the flavor compositions and pet food products have enhanced palatability.

This invention discloses a traditional Chinese medicine formula for preventing and treating feline urinary tract diseases, its preparation method, and its application. The formula consists of the following components in parts by weight: 15-25 parts of Psoralea corylifolia, 15-25 parts of Alpinia oxyphylla, 10-20 parts of Trigonella foenum-graecum, 5-15 parts of Zea mays, 5-15 parts of Juncus effusus, 10-20 parts of Dioscorea hypoglauca, 10-20 parts of Phellodendron chinense, 10-20 parts of Lonicera japonica, 5-15 parts of Paeonia lactiflora, and 5-15 parts of Glycyrrhiza uralensis. The traditional Chinese medicine formula provided by this invention has diuretic and urinary tract mucosal repairing effects. It can effectively relieve symptoms such as urinary stones, painful urination, hematuria, or gravel in the urine caused by damp-heat in the lower abdomen. It promotes the repair of the urinary tract mucosa in animals with urinary tract diseases, alleviates inflammatory responses, and prevents the formation of crystals in the urine.

An article of manufacture according to the present invention comprises a composition including a glycosaminoglycan, a local anesthetic, and a buffer packaged in a syringe or vial constructed from either glass or a plastic selected from the group consisting of cyclic olefin polymer, cyclic olefin copolymer, or high density non-nucleated polypropylene. The composition has unexpectedly improved stability on storage. The composition can be formulated for treatment of a urinary tract disease or condition, such as interstitial cystitis, also known as bladder pain syndrome or hypersensitive bladder syndrome.

The utility model relates to the technical field of catheterization devices, in particular to a urinary disease nursing leakage-proof catheterization device which comprises a catheter and a catheterization bag, the bottom end of the catheter is connected with a connecting seat, a connecting groove is formed in the bottom wall of the connecting seat, an inserting pipe is fixedly arranged on the inner wall of the top of the connecting groove, and a through hole communicated with the inserting pipe is formed in the top wall of the connecting seat. A passage of the through hole is closed through the valve, limiting of the guide block is relieved through the fixing assembly, and therefore the connector and the connecting base can be rapidly separated, the structure has the effect of facilitating replacement of the catheterization bag and the effect of preventing leakage when the catheterization bag is replaced, operation is easy, and practicability is high.

The present disclosure relates to a systemically administered peptide delivery platform that biodistributes to the kidney or urinary tract. The disclosure further relates to methods of treating a disease of the kidney or urinary tract in a subject in need thereof.

The invention relates to the technical field of medical diagnosis and artificial intelligence, in particular to a urinary tract disease prediction system based on multi-modal chromosome abnormality and clinical data, which integrates demographic statistics, clinical symptoms, laboratory detection, molecular biology of nine key chromosome sites and multi-dimensional data of images, and performs pre-processing and single-modal feature extraction to obtain a prediction result of the urinary tract disease. Fusion features are generated in a targeted mode through a task self-adaption fusion module, and then urinary tract epithelial cancer or neoplastic lesion positive prediction, positive sample TNM staging and pathological grading prediction and focus origin positioning are achieved through a multi-task model. According to the system, an edge cloud collaborative architecture is adopted, the computing power requirements of different medical institutions are met, the feature contribution degree is determined through an SHAP method, a visual clinical report is generated, the problems that in the prior art, multi-modal data integration is insufficient, and non-invasive staging and grading are lacked are solved, prediction reliability and clinical adaptability are improved, and support is provided for clinical auxiliary decision making.

The invention provides a cat prescription food for improving lower urinary tract diseases and a preparation method thereof, and the cat prescription food for improving urinary tract calculi comprises the following components in percentage by mass: a grain-free hypoallergenic raw material, chicken oil, yolk powder, chicken liver powder, fish oil, a Chinese herbal medicine raw material, cellulose, casein hydrolysate and 1-10% of a premix. By using the cereal-free low-sensitivity raw materials, the health of intestinal tracts can be cared; by adjusting the proportion of calcium, phosphorus, magnesium and other minerals, mineral balance of urine can be maintained, and by matching with herbaceous plant ingredients such as semen plantaginis, urination is promoted, and the calculus risk is reduced; by adding citrate, the combination of citrate and calcium ions is promoted, a soluble calcium citrate compound is formed, and the crystallization and deposition of calcium oxalate can be reduced; by controlling the protein content and adding the acidifying agent, weak acid urine can be maintained, bacterial growth can be inhibited, and struvite crystal dissolution can be promoted.